Our structural biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.
Structural-Based Drug Design (SBDD) De novo Drug Design Virtual Drug Screening Quantitative Structure-Activity Relationship (QSAR) ADMET Property Optimization
In-house fragment library designed by medicinal chemists Construct focused library on the target knowledge using molecular modeling Screen fragments mainly using X-ray technology Design novel scaffolds based on crystal structures
Antibody Screening Chemical Drugs, Small Molecule Drugs and Natural Medicine Screening Antibody Characterization Chemical Drugs, Small Molecule Drugs and Natural Medicine Characterization
